Tag Archives: AstraZeneca

A Wall Street Journal investigation has uncovered an industry-wide practice of pharmaceutical companies outsourcing drug safety monitoring, which may potentially affect the level of safety oversight in the market.

Outsourced Drug Safety Monitoring Feeds a Growing $2 Billion Industry

A Wall Street Journal investigation has uncovered an industry-wide practice of pharmaceutical companies outsourcing drug safety monitoring, which may potentially affect the level of safety oversight in the market. Drug giants like AstraZeneca, Bristol-Myers Squibb, and Novartis have started farming out these functions, such as analysis of side effect reports, to companies located...
Read more

Real Time Analytics